Australia markets closed

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
117.28-2.72 (-2.27%)
At close: 04:00PM EST
117.08 -0.20 (-0.17%)
After hours: 07:21PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
1,783,900
1,488,700
1,133,500
1,045,900
788,100
Cost of revenue
38,900
23,200
14,300
10,100
7,400
Gross profit
1,745,000
1,465,500
1,119,200
1,035,800
780,700
Operating expenses
Research development
545,500
463,800
328,100
275,000
200,000
Selling general and administrative
851,600
752,700
583,300
433,300
354,100
Total operating expenses
1,397,100
1,216,500
911,400
708,300
554,100
Operating income or loss
347,900
249,000
207,800
327,500
226,600
Interest expense
4,600
7,100
25,800
32,800
32,000
Total other income/expenses net
-91,500
-28,000
-80,600
-188,000
-148,100
Income before tax
251,800
213,900
101,400
106,700
46,500
Income tax expense
60,800
59,400
11,800
-300,600
9,500
Income from continuing operations
191,000
154,500
89,600
407,300
37,000
Net income
191,000
154,500
89,600
407,300
37,000
Net income available to common shareholders
191,000
154,500
89,600
407,300
37,000
Basic EPS
1.97
1.61
0.95
4.38
0.40
Diluted EPS
1.90
1.56
0.92
4.16
0.39
Basic average shares
97,225
95,800
94,600
93,100
91,600
Diluted average shares
100,625
98,900
97,900
97,800
95,700